Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
SEC Accession No. 0000950123-10-079658
Filing Date
2010-08-23
Accepted
2010-08-20 17:40:48
Documents
10
Effectiveness Date
2010-08-23

Document Format Files

Seq Description Document Type Size
1 DEFM14A y85574dmdefm14a.htm DEFM14A 3012323
2 GRAPHIC y85574dmy8557404.gif GRAPHIC 1878
3 GRAPHIC y85574dmy8557405.gif GRAPHIC 1549
4 GRAPHIC y85574dmy8557406.gif GRAPHIC 1097
5 GRAPHIC y85574dmy8557407.gif GRAPHIC 2399
6 GRAPHIC y85574dmy8557408.gif GRAPHIC 2663
7 GRAPHIC y85574dmy8557409.gif GRAPHIC 1002
8 GRAPHIC y85574dmy8557403.gif GRAPHIC 1203
9 GRAPHIC y85574dmy8557401.gif GRAPHIC 1503
10 GRAPHIC y85574dmy8557412.gif GRAPHIC 3082
  Complete submission text file 0000950123-10-079658.txt   3037871
Mailing Address ONE ENTERPRISE ALISO VIEJO CA 92656
Business Address ONE ENTERPRISE ALISO VIEJO CA 92656 949-461-6000
VALEANT PHARMACEUTICALS INTERNATIONAL (Filer) CIK: 0000930184 (see all company filings)

EIN.: 330628076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFM14A | Act: 34 | File No.: 001-11397 | Film No.: 101030921
SIC: 2834 Pharmaceutical Preparations